<DOC>
	<DOCNO>NCT00661661</DOCNO>
	<brief_summary>The purpose study determine long-term effectiveness safety CP-690,550 treatment rheumatoid arthritis . Subjects eligible study complete participation another `` qualifying '' study CP-690,550 .</brief_summary>
	<brief_title>Long-Term , Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects complete participation randomize `` qualify '' study CP690,550 treatment rheumatoid arthritis Serious medical condition would make treatment CP690,550 potentially unsafe</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Long term open label study Japan</keyword>
	<keyword>CP-690</keyword>
	<keyword>550</keyword>
	<keyword>tofacitinib</keyword>
</DOC>